ORBI Risk Score: Clinical Validation Data for Cardiogenic Shock Prediction

2,713 adult STEMI patients without cardiogenic shock at admission were prospectively registered at a tertiary hospital between 2022 and 2025. The data validates the ORBI risk score for predicting in-hospital cardiogenic shock, with results showing an AUC of 0.89. The supplementary material was authored by figshare admin karger and published on figshare in 2026.

Use Cases

• Validate a clinical risk score based on pre- and post-procedural angiographic variables.
• Assess model calibration and discrimination for post-procedural clinical endpoints.
• Analyze the performance of a risk score across different risk strata (low, intermediate, high).

Strengths

• Prospective validation cohort of 2,713 patients.
• Strong model discrimination reported with an AUC of 0.89.
• Clear risk stratification results showing CS incidence from 1.0% to 40% across score groups.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count for the underlying data is unknown, which may limit suitability assessment.
• Data is from a single tertiary hospital, which may reflect geographic or institutional bias.

Provenance

Source

figshare admin karger

Collection Method

Prospective registry of consecutive adult STEMI patients at a tertiary hospital.

Time Range

2022-2025

Freshness

Last updated 2026-05-16 07:55:18